Latest Boardroom Shifts News

Hancock & Gore reports a statutory loss for FY25 amid major acquisitions and strategic transformation, setting sights on $200m revenue by FY27 as it rebrands to Schoolblazer Limited.

Electro Optic Systems has resolved ASIC's investigation into its 2022 revenue guidance breaches by agreeing to a $4 million penalty, paving the way for renewed focus on growth and governance.

Synertec Corporation reported resilience in FY25 despite sector headwinds, with a strong rebound in engineering profits and a 90% revenue jump in its renewable Powerhouse technology.

Alicanto Minerals has appointed seasoned resources executive Jeffrey Sansom as CEO, signaling a strategic push to advance its Falun Copper-Gold Project and pursue new acquisitions. The leadership change aligns with the company’s ambitions to enhance shareholder value through disciplined growth.

Global Masters Fund Limited (GFL) reported a robust 19.8% total return for FY2025, surpassing the MSCI World Index, while unveiling strategic moves to diversify beyond Berkshire Hathaway into private growth and regional quality funds.

Metcash Limited has responded to an ASX query regarding the late filing of a director’s interest notice, attributing the delay to an administrative oversight and outlining plans to enhance compliance processes.

Aguia Resources has appointed Tim Hosking as its new CEO, signaling a strategic push towards phosphate production in Brazil set for early 2026, while addressing operational challenges at its Colombian gold project.

Solvar Limited has sold its New Zealand arrears loan book for NZ$8 million, accelerating its exit from the NZ market and announcing a special fully franked dividend for shareholders.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Fleetwood Limited has announced the immediate departure of CEO Bruce Nicholson, with Chair John Klepec stepping in as interim CEO while a search for a permanent replacement begins.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Bapcor Limited has reshaped its leadership with Lachlan Edwards appointed as Chair and Angus McKay stepping down from the Board to concentrate on turning around the business as CEO.